Spotlight
Clinical
Events
CME
Partners
Subscribe
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Effect of immediate therapy in early glaucoma confirmed
Anaheim, CA-The Early Manifest Glaucoma Trial (EMGT) has provided the first estimate of treatment effectiveness in patients with early open-angle glaucoma. M. Cristina Leske, MD, MPH, described the findings of the trial and how they relate to clinical practice here at the American Academy of Ophthalmology annual meeting.
Related Videos
Related Content
